Company lists
The Delhi edition · 2026

Biopharma outsourcingcompanies in Delhi

CDMO, API & small molecules, CRO, consulting & regulatory, logistics & packaging and more: the companies building biopharma outsourcing in Delhi, with their founders, funding, team size and business models.

132 company profiles66 with reported revenue3 with recorded fundingOctober 2026 edition
Delhi · Photo: Wikimedia Commons (Creative Commons Attribution-ShareAlike 4.0)

Recent biopharma outsourcing business events in India

Funding, M&A, contract wins and launches involving 2,490 biopharma outsourcing companies in India, last 24 months: 82 M&A deals · 18 Contracts · 18 funding rounds · 3 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.

M&AAcquisition · Announced

Skymap pharmaceuticals acquires Indian Medicines Pharmaceutical Corporation Ltd

The Indian government has officially approved the acquisition of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL) by Skymap Pharmaceuticals Pvt Ltd for ₹121 crore.

Pharmaceuticals
M&AAcquisition · Announced

True north acquires Embio

According to reports, True North invested about INR 478 crores to acquire a 25 percent stake in Embio.

Pharmaceuticals
M&AAcquisition · Completed

Sunways acquires Indoco remedies

Indoco Remedies has successfully completed the transfer of its ophthalmic business division to Sunways (India) Private Limited. This strategic move, finalised on May 18, 2026, involves…

Pharmaceuticals
M&AAcquisition · Announced

Gujarat themis biosyn acquires Sanofi

Introduction Shares of Gujarat Themis Biosyn Ltd surged sharply after the company announced a major acquisition deal with Sanofi.

Pharmaceuticals
LaunchSynchronous Motors Market Size 2026 Report

Datam intelligence

DataM Intelligence has unveiled its latest report on the 'Synchronous Motors Market Size 2026' delivering powerful insights into key trends, future growth opportunities, and evolving…

Report
ContractSupply

Panacea biotec · client: Central Medical Services Society (CMSS)

Panacea Biotec has announced the receipt of a Letter of Award from the Central Medical Services Society (CMSS), under the Ministry of Health and Family Welfare, Government of India. The…

Healthcare
M&AAcquisition · Completed

Jubilant ingrevia acquires Remidex Pharma

Jubilant Ingrevia has successfully acquired a 100% equity stake in Remidex Pharma Private Limited.

Pharmaceutical
M&AMerger · Announced

EPL acquires Indovida India Private Limited

EPL Limited and Indovida India Private Limited have today signed definitive agreements for a merger. The combined platform will have a valuation of ~$2 billion.

Rigid PET packaging
ContractTechnology

Shilpa Biologicals · client: Steincares

SteinCares, a specialty healthcare company in Latin America, entered into a strategic licensing agreement with Shilpa Biologicals Pvt. Ltd.

Healthcare
M&AAcquisition · Rumored

Consortium led by Warburg Pincus and Mubadala acquires Encube ethicals

Separately, a consortium led by Warburg Pincus and Abu Dhabi-based sovereign investor Mubadala is in advanced talks to buy a majority stake in contract manufacturer Encube Ethicals, ET…

Manufacturing
M&AAcquisition · Rumored

Warburg Pincus and Mubadala acquires Encube ethicals

Separately, a consortium led by Warburg Pincus and Abu Dhabi-based sovereign investor Mubadala is in advanced talks to buy a majority stake in contract manufacturer Encube Ethicals

Contract Manufacturing
M&AAcquisition

Dishman Pharmaceuticals and Chemicals acquires Carbogen-Amcis

Dishman Pharmaceuticals and Chemicals (Ahmedabad, India) with its acquisition of Carbogen-Amcis from Solutia

M&AAcquisition · Completed

Eris lifesciences acquires SWISS PARENTERALS

New Delhi: Eris Lifesciences Limited has completed the acquisition of the remaining 30 percent stake in Swiss Parenterals Limited, making it a wholly owned subsidiary

FundingZero-coupon bonds

Jubilant bhartia group

Two Jubilant Bhartia Group subsidiaries raised a combined 56.50 billion rupees through zero-coupon bonds in June to fund the acquisition of a 40% stake in Hindustan Coca-Cola Holdings.

M&AAcquisition · Announced

Aurobindo pharma acquires Khandelwal laboratories

Aurobindo Pharma, a wholly owned subsidiary of Aurobindo Pharma, at its meeting held on Monday, i.e., January 1, 2026, has approved the acquisition of the non-oncology prescription…

Pharmaceuticals
M&AAcquisition · Completed

Cactus acquires Baker Hughes Company’s Surface Pressure Control business

Cactus, Inc. today announced the completion of the acquisition of a majority interest in Baker Hughes Company’s Surface Pressure Control business.

Oil & Gas Services
M&AAcquisition · Completed

Auro pharma acquires Khandelwal laboratories

Aurobindo Pharma Ltd said its wholly owned arm, Auro Pharma Ltd, has acquired the branded non-oncology prescription formulations business of Khandelwal Laboratories Private Ltd on a…

Pharmaceuticals
M&AAcquisition · Announced

Piramal Pharma acquires Hemmo pharmaceuticals

Piramal Pharma Limited (PPL) has entered into an agreement to acquire a 100% stake in Hemmo Pharmaceuticals Pvt. Ltd., an Indian manufacturer of synthetic peptide APIs (active…

ContractSupply

Panacea biotec · client: Unicef

Earlier in October, UNICEF also placed a significant order for polio vaccines. Panacea Biotec received the letter of award (LoA) as part of a long-term agreement to supply bOPV in 10 and…

Healthcare
M&AAcquisition · Announced

Nowonomics acquires Centaur

On Wednesday, Dec. 10, it was announced that Swedish fund management company Centaur is selling its Sweden Quality fund to Nowonomics.

Fund management
M&AAcquisition · Announced

Eris lifesciences acquires SWISS PARENTERALS

Shardul Amarchand Mangaldas & Co. (SAM) acted as the legal advisor to Eris Lifesciences Limited (“ELL”) in connection with its proposed acquisition of 30% of the total share capital of…

M&AMerger · Announced

Sequent scientific acquires Viyash Lifesciences

The National Company Law Tribunal (NCLT) has approved the merger of SeQuent Scientific, a leading player in the global animal health industry, and Viyash Lifesciences, an integrated…

M&AAcquisition · Completed

Quadria capital acquires Encube ethicals

Quadria Capital bought around 15% in Encube for $100-120 million in June 2021, valuing it close to $1 billion.

Contract drug maker
M&AAcquisition · Announced

Ang lifesciences india acquires Mansa Print & Publishers

ANG Lifesciences India, a fast-growing organisation with an ultra-modern fully integrated, manufacturing facility dedicated to dry powder injectables (SVP), has acquired the printing and…

Printing & Packaging
M&AAcquisition · Rumored

Na acquires Encube ethicals

Global private equity firms Advent International and Warburg Pincus have joined the race for a stake purchase in contract drug maker Encube Ethicals Pvt. Ltd.

Contract drug maker / CDMO
M&AAcquisition · Announced

Intocell acquires Piramal pharma solutions

Piramal Pharma Solutions signed a memorandum of understanding with IntoCell to develop ADCs.

M&AAcquisition · Announced

Piramal pharma solutions acquires Intocell

Piramal Pharma Solutions signed a memorandum of understanding with IntoCell to develop ADCs.

Biotechnology / ADC development
M&AAcquisition · Announced

Jusmiral Holdings Limited acquires Cohance lifesciences

Shardul Amarchand Mangaldas & Co. (SAM) acted as the legal advisor for an on-market sale of 8.93% shareholding in Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited)…

M&AMerger · Completed

Cohance acquires Suven

SAM also advised on the subsequent merger of Cohance with and into Suven, upon which Suven was renamed as Cohance.

Biopharma outsourcing companies in Delhi, by revenue

Browse biopharma outsourcing companies in Delhi by reported revenue, one-year revenue growth, revenue model, age and stage. The 50 companies below are the largest by their most recent reported revenue among 66 biopharma outsourcing companies in Delhi that have filed a figure in the last four years. Every figure keeps its own reporting period, so compare periods before comparing amounts.

Showing 25 of 50

CDMO focusing on spectrum of dosage forms and therapeutic segments

Biopharma outsourcing
₹4,170.28 crFY 2024-25
-1%2024–2025
5,393+2% 12 mo to Jun 2023LinkedIn · Oct 2026
22 yr2004
0none in 3 months

Manufacturer of cancer & other drugs

Traditional pharmaceuticals
₹463.57 crFY 2023-24
+10%2023–2024
500LinkedIn · Oct 2026
33 yr1993
1postings · last posted Aug 2026

Provider of formulation development, regulatory affair, and supply chain management services

Biopharma outsourcing
₹404.31 crFY 2024-25
+5%2024–2025
340LinkedIn · Jul 2026
19 yr2007
0none in 3 months

Manufacturer specializing in injectable antibiotics

Biopharma outsourcing
₹383.30 crFY 2024-25
+1%2024–2025
249LinkedIn · Oct 2026
35 yr1991
0none in 3 months

Provider of pharmaceutical packaging services

Biopharma outsourcing
₹323.25 crFY 2024-25
+8%2024–2025
97+72% 12 mo to Sep 2024LinkedIn · Jul 2026
16 yr2010
0none in 3 months · last posted Apr 2026

CDMO focused on manufacturing API

Traditional pharmaceuticals
₹251.52 crFY 2024-25
+21%2024–2025
23+28% 12 mo to Aug 2024recorded Aug 2024
13 yr2013
0none in 3 months

Traditional company manufacturing bulk drugs and finished formulations

Biopharma outsourcing
₹217.98 crFY 2023-24
Not reported
936+35% 12 mo to Sep 2024LinkedIn · Oct 2026
62 yr1964
0none in 3 months · last posted Jun 2026

Research-driven pharmaceutical company focused on manufacturing and supplying a range of medicines for various therapeutic areas

Biopharma outsourcing
₹214.07 crFY 2024-25
+8%2024–2025
—Not available
32 yr1994
0none in 3 months

Manufacturer of pharmaceutical formulations

Biopharma outsourcing
₹209.40 crFY 2024-25
+46%2024–2025
376+13% 12 mo to Feb 2024LinkedIn · Oct 2026
19 yr2007
0none in 3 months

Importer and supplier of pharmaceutical APIs and bulk drugs

Traditional pharmaceuticals
₹159.80 crFY 2021-22
Not reported
3LinkedIn · Jul 2026
11 yr2015
0none in 3 months

Manufacturer and exporter of Corticosteroids, APIs and Vitamins

Biopharma outsourcing
₹177.98 crFY 2024-25
Not reported
9LinkedIn · Jul 2026
20 yr2006
0none in 3 months

Manufacturer of tablets, capsules, syrups, ointments and ORS

Biopharma outsourcing
₹168.79 crFY 2024-25
-7%2024–2025
291-0% 12 mo to Jul 2024LinkedIn · Oct 2026
33 yr1993
0none in 3 months · last posted Apr 2026

Manufacturer of phytochemicals, active pharmaceutical ingredients, and standardized herbal extracts

Diversified chemicals
₹141.02 crFY 2024-25
+39%2024–2025
75recorded
21 yr2005
1postings · last posted Aug 2026

Provider of medicines distribution services

Biopharma outsourcing
₹138.01 crFY 2024-25
+52%2024–2025
—Not available
14 yr2012
1postings · last posted Aug 2026

Manufacturers of Active Drug Ingredients

Biopharma outsourcing
₹126.90 crFY 2024-25
+11%2024–2025
141+35% 12 mo to Aug 2024LinkedIn · Jul 2026
30 yr1996
1postings · last posted Sep 2026

Pharma company offering a portfolio of injectables, tablets and capsules and also offering contract manufacturing services

Biopharma outsourcing
₹121.56 crFY 2024-25
+7%2024–2025
181+12% 12 mo to Sep 2024LinkedIn · Oct 2026
26 yr2000
0none in 3 months

Provider of quality assurance and regulatory affairs services to biopharma sector

Biopharma outsourcing
₹114.99 crFY 2022-23
Not reported
176+13% 12 mo to Sep 2024LinkedIn · Oct 2026
50 yr1976
—No postings tracked

Manufacturer and supplier of APIs & Intermediates in India

Biopharma outsourcing
₹120.24 crFY 2024-25
+13%2024–2025
205-13% 12 mo to Jul 2024recorded Jul 2024
19 yr2007
0none in 3 months

Pharmaceutical company specializing in contract manufacturing of pharmaceutical formulations

Biopharma outsourcing
₹111.56 crFY 2024-25
+3%2024–2025
84+6% 12 mo to Sep 2024recorded Sep 2024
10 yr2016
0none in 3 months

Research-driven pharmaceutical company with EU GMP compliance, manufacturing a range of solid and liquid oral medications and nutraceuticals

Biopharma outsourcing
₹96.06 crFY 2024-25
+17%2024–2025
—Not available
25 yr2001
0none in 3 months

Maufacturer of APIs and intermediates

Biopharma outsourcing
₹94.75 crFY 2024-25
+35%2024–2025
14LinkedIn · Jul 2026
20 yr2006
0none in 3 months

Provider of pharmaceutical contract manufacturing solutions

Biopharma outsourcing
₹90.64 crFY 2024-25
+2%2024–2025
—Not available
19 yr2007
0none in 3 months

Cold chain logistics solutions for pharmaceuticals, medical and other industries.

Biopharma outsourcing
₹82.54 crFY 2024-25
+7%2024–2025
174-27% 12 mo to Sep 2024LinkedIn · Oct 2026
11 yr2015
0none in 3 months

Manufacturer of pharmaceutical formulations

Pharmaceutical distributors
₹70.77 crFY 2024-25
-6%2024–2025
1LinkedIn · Jul 2026
21 yr2005
0none in 3 months

Manufacturing and exporting of pharmaceutical formulations , trading of raw materials and Research & Development for pharmaceutical Industry

Biopharma outsourcing
₹64.16 crFY 2024-25
-9%2024–2025
315-10% 12 mo to Sep 2024recorded Sep 2024
41 yr1985
0none in 3 months
50 of 132 companies shown here · the full list is on Radar
Fliar Radar

Explore all 132 biopharma outsourcing companies in Delhi on Radar

This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.

Open biopharma outsourcing in Delhi on Radar
  • Every company, not just 50All 132 biopharma outsourcing companies in Delhi, filterable by stage, funding, team size, revenue model and age.
  • Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
  • Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
  • Save and exportBuild lists, compare companies side by side and export them from your Radar account.

Explore biopharma outsourcing companies in Delhi by what you are looking for

Browse top biopharma outsourcing companies in Delhi, including CDMOs, API manufacturers and clinical research providers. You can also find biopharma outsourcing startups in Delhi and see which companies are hiring.

8 ways to explore biopharma outsourcing in Delhi

CDMO & pharma contract manufacturing companiesAPI & small molecule drug manufacturersClinical research (CRO) & development servicesPharma consulting & market research servicesPharma logistics & packaging providersListed biopharma outsourcing companies in Delhi

CDMO & pharma contract manufacturing companies

Contract development and manufacturing organisations producing formulations and dosage forms.

  1. Akums

    CDMO focusing on spectrum of dosage forms and therapeutic segments

    Biopharma outsourcing
    See in list
  2. Zee Laboratories

    Manufacturer of cancer & other drugs

    Traditional pharmaceuticals
    See in list
  3. Mascot Health Series

    Provider of formulation development, regulatory affair, and supply chain management services

    Biopharma outsourcing
    See in list
  4. Rajasthan Antibiotics

    Manufacturer specializing in injectable antibiotics

    Biopharma outsourcing
    See in list
  5. Pretty Petals

    CDMO focused on manufacturing API

    Traditional pharmaceuticals
    See in list

API & small molecule drug manufacturers

Manufacturers and suppliers of active pharmaceutical ingredients and generics.

  1. Zee Laboratories

    Manufacturer of cancer & other drugs

    Traditional pharmaceuticals
    See in list
  2. Pretty Petals

    CDMO focused on manufacturing API

    Traditional pharmaceuticals
    See in list
  3. Supermax

    Research-driven pharmaceutical company focused on manufacturing and supplying a range of medicines for various therapeutic areas

    Biopharma outsourcing
    See in list
  4. Eppion Life Sciences

    Importer and supplier of pharmaceutical APIs and bulk drugs

    Traditional pharmaceuticals
    See in list
  5. Mahima Life Sciences

    Manufacturer and exporter of Corticosteroids, APIs and Vitamins

    Biopharma outsourcing
    See in list

Clinical research (CRO) & development services

Contract research organisations offering clinical development and bioanalytical services.

  1. Auriga Research

    CRO providing services for clinical trials, bioequivalence studies and formulation development

    Biopharma outsourcing
    See in list
  2. CliniExperts

    A regulatory consultant

    Biopharma outsourcing
    See in list
  3. Althea DRF Lifesciences

    Healthcare and wellness company providing technical and scientific support to global biotech companies

    Biopharma outsourcing
    See in list
  4. Dhiti Life Sciences

    Biotechnology company offering in vitro diagnostic products for healthcare sector

    Biopharma outsourcing
    See in list
  5. Presude

    Manufacturer of chemicals for research purposes

    Chemical services
    See in list
26 companies in Delhi

Pharma consulting & market research services

Consulting, regulatory and market research providers for pharma companies.

  1. Weldon Biotech

    Provider of sales and marketing services for diagnostics reagents and instruments

    Biopharma outsourcing
    See in list
  2. Accredited Consultants

    Provider of regulatory, consulting and pharmacovigilance services to biopharma

    Biopharma outsourcing
    See in list
  3. Biosilt

    Provider of marketing services to biopharma sector

    Biopharma outsourcing
    Website
  4. Intelly Regocom

    Provider of regulatory and product launch consulting services for the nutraceutical companies

    Biopharma outsourcing
    Website
  5. NKG

    Provider of regulatory and business consulting services

    Biopharma outsourcing
    Website
18 companies in Delhi

Pharma logistics & packaging providers

Cold chain, courier and packaging services for pharmaceutical shipments.

  1. Alutech Packaging

    Provider of pharmaceutical packaging services

    Biopharma outsourcing
    See in list
  2. JEETO Biocourier

    Provider of logistics for life science, pharmaceutical, and biological materials

    Cold chain logistics
    Website
  3. Credent Cold Chain Logistics

    Cold chain logistics solutions for pharmaceuticals, medical and other industries.

    Biopharma outsourcing
    See in list
  4. CMG Biotech

    Manufacturer of pharmaceutical formulations

    Pharmaceutical distributors
    See in list
  5. Tempcon Express

    Cold chain logistics brand providing freight solutions to the healthcare, pharmaceutical, and clinical trial industry

    Biopharma outsourcing
    See in list

Listed biopharma outsourcing companies in Delhi

Publicly listed pharma manufacturers and outsourcing companies based in Delhi.

  1. Akums

    CDMO focusing on spectrum of dosage forms and therapeutic segments

    Biopharma outsourcing
    See in list
  2. Jagsonpal

    Traditional company manufacturing bulk drugs and finished formulations

    Biopharma outsourcing
    See in list
  3. Medicamen

    Manufacturer of tablets, capsules, syrups, ointments and ORS

    Biopharma outsourcing
    See in list
  4. Sunil Healthcare

    Provider of quality assurance and regulatory affairs services to biopharma sector

    Biopharma outsourcing
    See in list
  5. Kimia Biosciences

    Manufacturer and supplier of APIs & Intermediates in India

    Biopharma outsourcing
    See in list
5 companies in Delhi

Biopharma outsourcing startups in Delhi

Biopharma outsourcing companies founded in recent years.

  1. Acorn Research and Consultant

    Market research firm

    Biopharma outsourcing
    Website
  2. EQOVA Medicare

    Manufacturer of finished pharmaceutical formulations and contract manufacturer

    Biopharma outsourcing
    Website
  3. GoodName India

    Supplier of API offering a range of nicotine products, including vegetable glycerine, nicotine alkaloids, synthetic nicotine, and nicotine dilutions, catering to the pharmaceutical industry

    Biopharma outsourcing
    Website
  4. Clinical Solutions Research

    Provider of site management services for clinical trials and research

    Biopharma outsourcing
    Website
  5. Ardentivis

    Provider of pharmacovigilance technology and business process transformation consulting services

    Biopharma outsourcing
    Website
13 companies in Delhi

Biopharma outsourcing companies hiring in Delhi

Biopharma outsourcing companies in Delhi with open roles.

  1. Zee Laboratories

    Manufacturer of cancer & other drugs

    Traditional pharmaceuticals
    See in list
  2. Alutech Packaging

    Provider of pharmaceutical packaging services

    Biopharma outsourcing
    See in list
  3. Jagsonpal

    Traditional company manufacturing bulk drugs and finished formulations

    Biopharma outsourcing
    See in list
  4. Medicamen

    Manufacturer of tablets, capsules, syrups, ointments and ORS

    Biopharma outsourcing
    See in list
  5. Sarv Biolabs

    Manufacturer of phytochemicals, active pharmaceutical ingredients, and standardized herbal extracts

    Diversified chemicals
    See in list
12 companies in Delhi
The business behind the activity

Biopharma outsourcing financials in Delhi

Revenue, profit and growth from the filed annual accounts of 72 biopharma outsourcing companies in Delhi for FY24-25 — 79 of the 132 companies on this page file accounts with the Ministry of Corporate Affairs. The five largest earn 47% of the revenue, so medians describe the typical company better than totals.

combined revenue, FY24-25₹5,711.79 cr

72 companies filing accounts

combined net profit₹413.91 cr

7.2% aggregate margin

are profitable86%

62 of 72 companies

median revenue~₹19.6 cr

the typical company

median revenue growth+6%

into FY24-25

earned by the top five47%

revenue concentration

Six-year view

Combined revenue of filing companies

₹3,559.07 crFY19-2068 filers
₹3,940.09 crFY20-2173 filers
₹5,091.41 crFY21-2271 filers
₹5,522.59 crFY22-2371 filers
₹5,966.55 crFY23-2471 filers
₹5,711.79 crFY24-2572 filers

The number of companies filing changes each year; the three-year cohort below compares like with like.

Like-for-like

The same 67 companies over three years

+11%
FY22-23₹5,099.56 cr₹309.85 cr net
FY23-24₹5,496.51 cr₹10.61 cr net
FY24-25₹5,654.59 cr₹416.21 cr net

Companies with accounts for all three years, so growth is not an artefact of who filed.

Scale and profit

Bigger companies are far more often profitable

Under ₹1 cr650% profitable
₹1–10 cr1979% profitable
₹10–100 cr3190% profitable
₹100–1,000 cr15100% profitable
Over ₹1,000 cr1100% profitable

Companies by FY24-25 revenue. Bars show how many companies sit in each band.

Momentum

How fast revenue moved into FY24-25

Shrinking23
0–20%25
20–50%13
50–100%6
Doubled+2

69 companies with accounts for both years; median growth +6%.

Profitability

Profit is concentrated at the top

62profitable
10loss-making
7.2%aggregate margin
3.0%median margin

The aggregate margin is pulled up by a few large filers; the median shows the typical company.

Growth leaders · ₹10 cr+ revenue

Fastest growing, FY24-25

CompanyGrowthRevenue
Glee BiotechGLEE BIOTECH LIMITED
Unistar BiotechUNISTAR BIOTECH LIMITED
APCO PharmaAPCO PHARMA LIMITED
Dhiti Life SciencesDHITI LIFE SCIENCES PRIVATE LIMITED
Narang BiotecNARANG BIOTEC PRIVATE LIMITED+52%₹138.01 cr
Medicamen OrganicsMedicamen Organics Limited.
Profit leaders · ₹10 cr+ revenue

Highest net margins, FY24-25

CompanyMarginRevenue
ImmuneticIMMUNETIC LIFESCIENCES PRIVATE LIMITED27.0%₹13.68 cr
Coral DrugsCORAL DRUGS PRIVATE LIMITED24.7%₹126.90 cr
JagsonpalJAGSON PAL PHARMACEUTICALS LIMITED.20.0%₹276.91 cr
Jocund IndiaJOCUND INDIA LIMITED
Cooper PharmaCOOPER PHARMA LIMITED
Glee BiotechGLEE BIOTECH LIMITED
Inside the industry

Sub-sectors compared, FY24-25

Sub-sectorCompaniesRevenueMedian revenueProfitableMargin
Biopharma outsourcing65₹5,094.34 cr~₹18.8 cr85%7.7%
Leaders

Largest biopharma outsourcing companies by revenue, FY24-25

Company · legal entityRevenueNet resultMarginGrowth
AkumsAKUMS DRUGS AND PHARMACEUTICALS LIMITED₹1,435.98 cr₹161.00 cr11.2%-7%
Rajasthan AntibioticsRAJASTHAN ANTIBIOTICS LTD₹383.30 cr₹23.53 cr6.1%+1%
Alutech PackagingALUTECH PACKAGING PRIVATE LIMITED₹323.25 cr₹12.30 cr3.8%+8%
JagsonpalJAGSON PAL PHARMACEUTICALS LIMITED.₹276.91 cr₹55.36 cr20.0%+27%
Pretty PetalsPRETTY PETALS PRIVATE LIMITED₹251.52 cr₹6.35 cr2.5%+21%
SupermaxSUPERMAX DRUGS & PHARMACEUTICALS PRIVATE LIMITED₹214.07 cr₹18.39 cr8.6%+8%
Biodeal PharmaceuticalsBiodeal Pharmaceuticals Limited₹209.40 cr₹15.18 cr7.2%+46%
Mahima Life SciencesMAHIMA LIFESCIENCES PRIVATE LIMITED₹177.98 cr₹6.08 cr3.4%-18%
MedicamenMEDICAMEN BIOTECH LIMITED₹157.69 cr₹9.45 cr6.0%-10%
Baddi FoilsBADDI FOILS PRIVATE LIMITED₹149.58 cr₹1.47 cr-4%
Some figures are available to Radar members.Log in to Radar to see every figure

Standalone annual accounts filed with the Ministry of Corporate Affairs. Brands that share one legal entity are shown together and counted once.

Industry landscape report

AdTech Industry Landscape of Delhi

The financials above are one chapter. The full biopharma outsourcing landscape of Delhi maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.

  • Market map of every sub-sector
  • Funding & company formation by year
  • Revenue, profit & financial strength
  • Digital footprint: traffic, apps, releases
  • Hiring, skills & pay
  • Founders & leaders
  • News & sentiment
  • Where demand runs ahead of supply
Read the biopharma outsourcing landscape of Delhi
For investors and data teams

Put this intelligence into your own tools

The figures on this page come from Fliar’s company, funding and MCA filings data. Use it through the Investor Intelligence API and MCA financials feeds, or explore every company, filing and investor in Radar.

Capital & corporate activity

Biopharma outsourcing funding and M&A across India

193 recorded equity rounds have gone to 2,490 biopharma outsourcing companies in India — how much, at which stage, into which sub-sectors, from whom, and how Delhi compares. Debt, IPO and grant rounds are excluded.

equity rounds, last 12 months2

US$270.00m

equity rounds, last 24 months7

US$425.09m

raised over five yearsUS$1.28bn

51 rounds in India

M&A deals, India82

last 24 months

Capital by year

Equity funding into biopharma outsourcing in India

amount rounds
$84m201811
$134m20199
$62m202011
$435m202116
$315m202214
$90m20238
$19m20246
$155m20256
$270m20261

Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$435.16m across 16 rounds.

The funding ladder · five years

Rounds and typical cheque by stage

AngelUS$119.62m12 rounds · median US$500k
SeedUS$14.38m11 rounds · median US$1.29m
Series AUS$80.53m9 rounds · median US$4.40m
Series BUS$106.78m7 rounds · median US$16.27m
Series CUS$255.00m3 rounds · median US$80.00m
Series D+US$284.18m2 rounds · median US$142.09m
Private equityUS$423.40m7 rounds · median US$68.00m
Where the money went · five years

Most-funded sub-sectors

Biopharma outsourcingUS$982.10m45 rounds · 35 companies
Traditional pharmaceuticalsUS$271.81m2 rounds · 2 companies
Contract manufacturersUS$29.48m2 rounds · 2 companies
Medical research labsUS$500k1 rounds · 1 companies
Food safety testingUS$0k1 rounds · 1 companies
Corporate activity · last 24 months

M&A in India

68Acquisition
14Merger

Most active acquirers

  1. Jubilant bhartia group6
  2. Sequent scientific5
  3. Optimus4
  4. Eris lifesciences3
  5. Cactus3

Most acquired or merged

  1. Schott poonawalla7
  2. Encube ethicals4
  3. OTRS AG4
  4. SWISS PARENTERALS3
  5. Gland pharma3

Each deal appears in the events strip at the top of the page.

Founders and momentum in Delhi

Meet the people behind biopharma outsourcing companies in Delhi. 48 of 132 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.

Explore Delhi biopharma outsourcing companies by sub-sector

The most common specialisations among biopharma outsourcing companies in Delhi. Open a company to see what it sells, who runs it and how far it has come.

Keep exploring biopharma outsourcing in India and nearby markets.

Coming soon